OTC · CNGT
Cannagistics, Inc.
Financial Services · Shell Companies
$0.00
Up+$0.00 (+0.00%)
Updated Sep 19, 2026, 4:04 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 29.63K
- P/E ratio
- -0
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 11.61K
- Avg. volume
- 3.71K
Price performance
CNGT price history
1M range · 0 trading sessions · Daily adjusted prices
CNGT does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest CNGT news
The latest Smart Investors Daily articles mentioning CNGT.
Stock researchCompany · Overview
CNGT research
Overview
Company profile and research snapshot.
Company profile
Cannagistics, Inc. develops, markets, and sells OTC, pharmaceutical, nutraceutical, cosmetic, and health and wellness products. Its product portfolio includes Canagel, an anhydrous hydrogel composition and delivery system; Silverpro, a compression fabric; KidzStrips, a thin film children's toothpaste strip; and ImmuniZin, an immune booster, as well as HydroSoil, a novel fertilizer. The company also provides IcyEase, an ice pack for muscle/joint pain; Slim-D, an appetite-suppressant oral strip; Energy Lighting Strips for oral energy; Micro Voltage Trans Derm C for pain; and CBD 600, a hemp rich oral tincture. It offers products in the areas of pain relief, anti-aging, hygiene, energy, and immune system and biochemical support, as well as skin creams for treatment of disorders and rejuvenations. In addition, the company provides products for veterinary and agricultural use. It offers its products through wholesale and retail establishments, including brick and mortar stores; and ecommerce platforms. The company was formerly known as Precious Investments, Inc. and changed its name to Cannagistics, Inc. in May 2019. Cannagistics, Inc. was incorporated in 2004 and is based in Hauppauge, New York.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.

